ALMOND THERAPY: TARGETING THE AMYGDALA
1 total filings · 0 classes · Active since Dec 2021
ALMOND THERAPY: TARGETING THE AMYGDALA holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 35 (Advertising & Business) with 1 filings. The WikiTrademarks Expansion Score is 7/100, low — the brand is focused on defending its existing categories rather than expanding.
USPTO data refreshed October 1, 2026
Protect or track "ALMOND THERAPY: TARGETING THE AMYGDALA"
Watch this name and we'll alert you when anyone files a similar mark.
Informational only, not a legal opinion. Consult a trademark attorney before filing or enforcing.
Own this brand? Claim the profile to add your logo, story, and website.
Sign in to claimHow is ALMOND THERAPY: TARGETING THE AMYGDALA filing trademarks, and where is the portfolio expanding?
Filing Velocity (24 Months)
Nice Class Distribution
Activity Timeline
No activity recorded yet.
Recent Filings
| Serial No. | Mark | Filing Date | Status | Classes | Owner |
|---|---|---|---|---|---|
| 97182740 | ALMOND THERAPY: TARGETING THE AMYGDALA | Dec 21, 2021 | Registered | 035 Advertising & Business 036 Insurance & Finance 041 Education & Entertainment 042 Science & Technology 044 Medical & Beauty Services | PsiloTec Health Solutions Inc. |
Weekly visibility reports showing how ChatGPT mentions ALMOND THERAPY: TARGETING THE AMYGDALA, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.
FAQ: ALMOND THERAPY: TARGETING THE AMYGDALA trademark portfolio
What trademarks does ALMOND THERAPY: TARGETING THE AMYGDALA hold?
ALMOND THERAPY: TARGETING THE AMYGDALA holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 35 (Advertising & Business), Class 36 (Insurance & Finance), Class 41 (Education & Entertainment). The most recent filings are registered to PsiloTec Health Solutions Inc..
How many trademarks does ALMOND THERAPY: TARGETING THE AMYGDALA have at the USPTO?
WikiTrademarks tracks 1 USPTO trademark filings attributed to ALMOND THERAPY: TARGETING THE AMYGDALA. The brand has been actively filing since December 2021. The count updates daily as new filings are indexed from the USPTO bulk data feed.
In which NICE classes does ALMOND THERAPY: TARGETING THE AMYGDALA file most often?
ALMOND THERAPY: TARGETING THE AMYGDALA's most active class is NICE Class 35 (Advertising & Business), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.
Who owns the ALMOND THERAPY: TARGETING THE AMYGDALA trademark?
The most recent filings under the ALMOND THERAPY: TARGETING THE AMYGDALA mark are registered to PsiloTec Health Solutions Inc.. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.
Is ALMOND THERAPY: TARGETING THE AMYGDALA expanding into new categories?
The current WikiTrademarks Expansion Score for ALMOND THERAPY: TARGETING THE AMYGDALA is 7 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.
How can I track new ALMOND THERAPY: TARGETING THE AMYGDALA trademark filings?
Click the Watch Brand button at the top of this page to add ALMOND THERAPY: TARGETING THE AMYGDALA to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.
More on this portfolio: Compare ALMOND THERAPY: TARGETING THE AMYGDALA to another owner · Browse all NICE classes · Most valuable brands
Community notes
0 notesShare what you know about ALMOND THERAPY: TARGETING THE AMYGDALA and help the next person researching it.